Core Viewpoint - The company has decided not to adjust the conversion price of its convertible bonds despite triggering conditions for a downward adjustment, aiming to maintain investor confidence and protect their interests [1][2]. Group 1: Meeting Details - The fifth board meeting of the company was held on June 11, 2025, with all five directors present, including two independent directors [1]. - The meeting was conducted in compliance with relevant laws and regulations, ensuring its legality and validity [1]. Group 2: Bond Conversion Price Decision - The board unanimously approved the proposal not to adjust the conversion price of the "Zhongzhuang Zhuan 2" bonds, despite the stock price being below 85% of the conversion price for at least 15 trading days [1]. - The current conversion price is set at 4.08 yuan per share, and the decision was made after considering the company's fundamental situation and stock price trends [1]. - The board indicated that if the conditions for adjustment are triggered again, they will convene another meeting to decide on the matter [1].

Group 1 - The company has decided to lower the conversion price of its convertible bonds due to the stock price being below 85% of the current conversion price for at least 15 trading days within a 30-day period [1][2] - The new conversion price is set at RMB 4.80 per share, which complies with the requirements of being higher than the average trading price of the stock over the previous 20 trading days and the latest audited net asset value per share [2] - The adjustment to the conversion price will take effect on May 21, 2025, following the approval from the board and the shareholders' meeting [2][3] Group 2 - The company issued 11.6 million convertible bonds with a total value of RMB 116 million, which were approved by the China Securities Regulatory Commission [1] - The bondholders must abstain from voting during the shareholders' meeting regarding the adjustment of the conversion price [2] - The board's decision aims to protect the interests of bondholders and optimize the company's capital structure for long-term development [1][2]

Core Viewpoint - The company, Hainan Puli Pharmaceutical Co., Ltd., has announced that its convertible bonds will enter a delisting arrangement starting from April 28, 2025, with the last trading date expected to be May 21, 2025 [1] Group 1: Convertible Bond Details - The company issued 8.5 million convertible bonds with a face value of RMB 100 each, raising a total of RMB 850 million, with a net amount of RMB 837.86 million after deducting fees [2][3] - The convertible bonds were listed on the Shenzhen Stock Exchange on March 8, 2021, under the name "Puli Convertible Bonds" with the code "123099" [3] - The bond's conversion period began six months after the issuance date and will last until the maturity date of the bonds [4] Group 2: Conversion Price Adjustments - The conversion price of the bonds has been adjusted multiple times, with the latest adjustment setting it at RMB 19.76 per share effective from July 18, 2023 [8][9] - The board proposed to further lower the conversion price to RMB 11.22 per share effective from November 20, 2024, and subsequently to RMB 4.89 per share effective from January 23, 2025 [10][11] - The company has the authority to propose adjustments to the conversion price if the stock price falls below 85% of the current conversion price for a specified period [12][13]

证券代码：002822 证券简称：ST中装 公告编号：2025-058 债券代码：127033 债券简称：中装转2 深圳市中装建设集团股份有限公司 "中装转2"2025年 第一次债券持有人会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或者重大遗漏。 根据《深圳市中装建设集团股份有限公司公开发行可转换公司债券募集说明书》（以下简称"《可转债 募集说明书》"）《深圳市中装建设集团股份有限公司可转换公司债券持有人会议规则》的相关规定， 深圳市中装建设集团股份有限公司（以下简称"公司"）董事会召集的"中装转2"2025年第一次债券持有 人会议（以下简称"本次会议"）于2025年4月25日召开。现将本次会议召开情况公告如下： 一、会议召开的基本情况 1、会议届次："中装转2"2025年第一次债券持有人会议 2、会议召集人：公司第五届董事会。 3、会议主持人：董事兼副总裁赵海峰先生 4、会议召开的合法、合规性：本次债券持有人会议的召集、召开程序符合有关法律、行政法规、部门 规章、规范性文件和《公司章程》《债券持有人会议规则》等相关规定。 5、会议召开的时间：2025年4月25日 ...

Core Viewpoint - The company decided not to lower the conversion price of its convertible bonds, "洁特转债," despite triggering the downward adjustment clause due to stock price fluctuations [5][9][10]. Group 1: Board Meeting Decisions - The fourth board meeting was held on April 11, 2025, where all seven participating directors unanimously agreed not to lower the conversion price of "洁特转债" [1][9]. - The decision was made considering the company's long-term development and investor interests, amidst significant stock price volatility influenced by macroeconomic and industry changes [9][10]. Group 2: Conversion Price Adjustment Details - The initial conversion price for "洁特转债" was set at 48.23 yuan per share, adjusted to 48.09 yuan on June 6, 2023, and further to 48.02 yuan on July 4, 2024, due to corporate actions [6][7]. - The downward adjustment clause was triggered as the stock price fell below 40.82 yuan (85% of the conversion price) for at least 15 out of 30 consecutive trading days [8][9]. Group 3: Future Considerations - The company will not propose a downward adjustment for the next three months (until July 11, 2025), but will reassess the situation after this period if the clause is triggered again [2][10]. - The board will convene again to decide on any future adjustments post-July 12, 2025, if necessary [2][10].

Core Viewpoint - Ningbo Meinuo Pharmaceutical Co., Ltd. has decided not to adjust the conversion price of its convertible bonds, despite triggering the downward adjustment clause due to stock prices falling below 90% of the current conversion price for a significant number of trading days [2][8]. Group 1: Convertible Bond Overview - The company issued 520 million yuan worth of convertible bonds on January 14, 2021, with a maturity of six years and an initial conversion price of 37.47 yuan per share [3]. - The bond trading began on February 4, 2021, under the name "Meinuo Convertible Bonds" with the code "113618" [3]. Group 2: Conversion Price Adjustment History - The conversion price has been adjusted multiple times since issuance, including a reduction to 26.51 yuan per share after a rights issue in June 2022 and further adjustments leading to the current price of 25.84 yuan per share [4][5]. - The most recent adjustment occurred on July 12, 2024, when the price was set at 25.84 yuan per share following a rights distribution [5]. Group 3: Downward Adjustment Clause - The downward adjustment clause is triggered when the stock price falls below 90% of the conversion price for at least 15 out of 30 consecutive trading days [6]. - The board has the authority to propose a downward adjustment, which requires a two-thirds majority approval from shareholders [6]. Group 4: Recent Board Decision - On April 3, 2025, the board held a meeting and unanimously decided not to adjust the conversion price, citing significant fluctuations in stock prices due to macroeconomic factors [2][8][11]. - The board indicated that if the downward adjustment clause is triggered again within the next three months, they will also not propose an adjustment [8].